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Previewsgenetic exaggeration to recapitulate the
key features of AD.
Human clinical trials may provide a lab-
oratory to test theories about the etiology
of AD. Two large-scale prevention trials
are currently underway to test the effects
of anti-amyloid immunotherapy in people
with FAD. One trial will enroll subjects
with either APP or PS mutations, while
the second trial will focus on a large
Columbian kindred with a mutation in
PS1. If the trials succeed, they will provide
strong support for the Amyloid Cascade
Hypothesis. However, if they fail, what
can one conclude? Pharmacokinetic con-
siderations aside, the most likely explana-
tions are that: (1) the target (i.e., Ab) was
correct, but that the timing of intervention
and/or the antibody were wrong, or (2)
Ab was the wrong target. If the trials
fail to produce the expected results, thefindings in Xia et al. (2015) may provide
an early clue as to why.REFERENCES
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Circadian behavior in mammals is coordinated by neurons within the suprachiasmatic nucleus (SCN). In this
issue, Lee et al. (2015) and Mieda et al. (2015) applied state-of-the-art genetic tools to dissect the microcir-
cuits within the SCN generating circadian rhythmic behavior.One of the fundamental goals of neurosci-
ence is to link specific brain regions to
specific functions. While in many cases
this goal has proven elusive, an over-
whelming body of evidence shows that
the suprachiasmatic nuclei (SCN) of the
anterior hypothalamus are the site of
the master circadian pacemaker in
mammals. The SCN functions to synchro-
nize a network of circadian oscillations
throughout the body; the resulting circa-
dian rhythms have a profound impact on
our health and wellbeing. In addition to
the identification of the SCN as a key re-
gion regulating circadian activity, at thecellular level, we currently have a relatively
firm understanding of the transcriptional/
translational feedback loops that are
responsible for generation of these mo-
lecular oscillations. However, major gaps
remain in understanding circadian regula-
tion at the intermediate level of analysis,
including the roles of specific cell-types
within the SCN. Two exciting back-to-
back studies in this issue have applied
state-of-the-art genetics tools to analyze
the SCN and make headway in under-
standing its circuitry and its role in circa-
dian rhythmic behavior (Lee et al., 2015;
Mieda et al., 2015).Some of the challenges in studying the
function of the SCN and its subpopula-
tions lie in its structure. Anatomical
studies generally support the division of
the SCN into at least two subdivisions
including a dorsal (shell) region and a
ventral (core) region (Figure 1; top). At
the cellular/synaptic however, the SCN
can be likened to a tightly packed ball,
composed of GABAergic neurons whose
synaptic connections form more of a
plexus rather than an ordered structure
like the hippocampus, cortex, or cere-
bellum. Furthermore, an influential study
using fully isolated SCN neurons found85, March 4, 2015 ª2015 Elsevier Inc. 895
Figure 1. Schematic Illustrating the Key Findings
In this highly stylized representation, AVP-expressing neurons are localized in the shell region of the SCN
while NMS-expressing neurons are localized throughout the nucleus. NMS (blue) appear to be co-ex-
pressed with the majority of AVP (green) and VIP (orange) expressing neurons. Disrupting the molecular
clock in NMS or AVP neurons produced abnormal circadian rhythms. Lengthening the intracellular circa-
dian period of NMS neurons lengthens behavioral circadian period. Blocking synaptic transmission from
NMS neurons similarly leads to the loss of coherent circadian rhythms. These phenotypes were reversible
with appropriate genetic manipulations.
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cally localized class of cell-autonomous
oscillators (Webb et al., 2009). Instead,
Webb et al. proposed that different SCN
cell types have intrinsic circadian oscilla-
tion mechanisms, but that these oscilla-
tors are unstable and rely on network in-
teractions for stability. Without a clear
wiring diagram, it is hard to even pick
your target for cellular analysis. In addi-
tion, the SCN network is extremely resil-
ient in the face of perturbations. At a
genetic level, the clock genes can
compensate for the loss of one gene by896 Neuron 85, March 4, 2015 ª2015 Elsevieincreased expression of another. As an
example, Clock knockout (KO) mice that
lack the transcription factor CLOCK
hardly display any circadian phenotype,
likely because of compensation by
another transcription factor, NPAS2 (De-
Bruyne et al., 2007). To provide another
example, the SCN network will continue
to generate circadian oscillations at a
population level even when most of the
cell-autonomous oscillations are compro-
mised due to the loss of the Cry gene (Liu
et al., 2007). Like those old Timex
watches, the SCN can ‘‘take a lickingr Inc.and keep on ticking.’’ The potential
biological benefit of this redundancy in
the circadian mechanisms is clear, but
scientifically it is challenging to tease
apart the components of this circuit. To
delineate the circadian circuits, one
needs a new combination of approaches
ranging from computational analysis to
new genetic tools. The difficulties outlined
above in the analysis of this dynamic sys-
tems are by no means limited to the
specific microcircuits of the SCN, and
it seems likely that the lessons learned
in this ‘‘simpler’’ brain region can be
applied elsewhere in more complicated
circuits.
To date, the heterogeneity of the neu-
rons that make up the SCN has made it
difficult to specifically ablate or modify
gene expression function in the SCN.
Prior work (Husse et al., 2011) came
closest to SCN-specific genetic manipu-
lation with the use of a Synaptotagmin10
(Syt10) driver, which showed enriched
expression in the SCN, but with possible
off-target effects in other brain regions.
The ablation of a gene critical for circadian
rhythms, Bmal1, in Syt10+ cells resulted
in a greatly shortened free-running period
in locomotor activity, but interpretation of
the work was marred by incomplete Cre
recombinase excision at the Bmal1flx/flx
locus. In addition to using amore effective
Cre recombinase, the present studies
(Lee et al., 2015; Mieda et al., 2015)
make use of genetic manipulations to
address the relative importance of an
intact circadian oscillator in SCN neuronal
sub-types as defined by neuropeptidergic
content. A caveat to bear in mind is that
the genetic drivers used in both studies
also show some expression outside of
the SCN. In fact, Mieda and colleagues
(2015) acknowledge and deal with this
issue by specifically restoring gene
expression using focal injection of a
rescue viral construct in the SCN. Both
studies combine their specific genetic
drivers withBmal1 ablation, the only avail-
able mutation that fully disrupts the
molecular clock. The study by Lee and
colleagues (2015) goes even further in
their use of genetic tools in the SCN, spe-
cifically altering the speed of the molecu-
lar oscillator using the ClockD19 period-
lengthening mutation; holding one
component of the circadian oscillator
at a permanent high using Period2
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Previewsoverexpression; and, notably, blocking
synaptic transmission with a modified
tetanus light chain molecule (TeNT)
(Figure 1; middle/bottom, columns 1–3).
The tetanus-like molecule targets and
cleaves synaptobrevin, preventing vesic-
ular docking/fusion and hence synaptic
transmission, which is critical for synchro-
nization of SCN neurons. They also
elegantly employ the doxycycline-
induced tet-On system to reverse the re-
sulting phenotypes, thus demonstrating
that the effects of the genetic mutations
are functional and not a result of aberrant
development of the SCN circuitry.
Mieda and colleagues (2015) provide
new insights into the role of vasopressin
(AVP)-producing neurons of the SCN.
These neurons appear to generate the
most robust circadian oscillations, at least
at the level of gene expression. The neu-
rons in the SCN shell express AVP as
well as GABA. Although the peptide AVP
defines one of the SCN cell populations,
these neurons received so far less atten-
tion partly because the AVP-deficient
Brattleboro rats display little abnormality
in circadian pacemaking other than a
reduced amplitude in their behavioral
rhythms (Kalsbeek et al., 2010). More
recent work, however, has implicated
AVP in the coupling of SCN neurons (Li
et al., 2009; Yamaguchi et al., 2013), and
together the data is consistentwith the hy-
pothesis that cellular oscillators in AVP
neurons are required for high-amplitude
circadian output of the SCN. Mieda et al.
(2015) tested this hypothesis by ablating
Bmal1 from Avp producing neurons
(AVP+) (Figure 1;middle/bottom, right col-
umn). Behavioral analysis indicated that
thesemice exhibited a longer free-running
period of locomotor activity rhythms. As
expected with a reduced amplitude of
the circadian oscillator, the mutant mice
showed a faster re-entrainment to
changes in the light/dark cycle. Somewhat
unexpectedly for amousewith adisrupted
circadian clock in the dorsal SCN, the
mice also showed a reduced phase shift
induced by light and reduced clock gene
induction by light in ventral SCN regions.
While most photic information flows from
the ventral to the dorsal SCN, this finding
illustrates that the communication is bi-
directional. Importantly, the expression
of crucial SCN output genes Avp, Prok2,
and Rgs16 were drastically reduced inthe dorsal SCN in the mutants. Finally,
PERIOD2 bioluminescence rhythms in
the SCN had unstable and lengthened pe-
riods. At the behavioral levels, Avp-
Bmal1fl/fl showed abnormal circadian
rhythms.Critically, the abnormal circadian
rhythms in locomotor activity were
rescued by injections of an adeno-associ-
ated virus expressing Bmal1 into the SCN
of adult Avp-Bmal1fl/fl mice, which em-
phasizes the anatomical specificity of the
mutation’s impact. Future studies will
need to parse the impact of disrupting
the clock alone or intercellular communi-
cation alone in a defined set of cells.
As noted by Mieda et al., the phenotype
of the Avp-Bmal1fl/fl mutants cannot
be solely due to the loss of AVP expres-
sion, as mice without AVP receptors
still express fairly normal rhythms. The
study by Lee and colleagues (2015) shows
one possible strategy for parsing the
impact of disruption of cell-autonomous
clocks versus disruption of cellular
communication.
While AVP is a well-studied anatomical
marker within the SCN, very little is known
about neuromedin S (NMS). This peptide
has highly enriched expression within
the SCN and is the ligand for neuromedin
U receptors (Mori et al., 2005). Due to its
SCN-enriched expression, NMS repre-
sents an attractive genetic target for ex-
ploiting and understanding the organiza-
tion of the central circadian clock. In
their study, Lee and colleagues (2015)
demonstrate that a subpopulation of
SCN neurons expressing NMS play a crit-
ical role in regulating circadian behavior.
NMS+ neurons make up approximately
40% of SCN neurons, and NMS is co-ex-
pressed in AVP+ and VIP+ neurons
(Figure 1). When the period-lengthening
ClockD19 mutation was expressed in
NMS neurons, the behavioral rhythm and
PERIOD2 expression in the SCN ex-
hibited a longer circadian period charac-
teristic of this mutation in a reversible
manner (Figure 1). In addition, knocking
out of Bmal1 in these neurons caused
disruption of the behavioral rhythm and
of PERIOD2 expression in the SCN. Over-
expression of PERIOD2 selectively in
NMS neurons also disrupted behavioral
rhythmicity and SCN synchronization.
Finally, inhibition of synaptic transmission
from NMS neurons resulted in arrhythmic
behavioral rhythms and desynchronizedNeuronPERIOD2 expression in the SCN. This
final clincher of an experiment demon-
strates the power of the new genetic tools
in mammals, previously only available to
Drosophila geneticists. The necessity of
synaptic transmission in the SCN for
behavioral rhythmicity could previously
only be tested in ex vivo or in vitro sys-
tems, which hence lacked the critical link
of brain-to-behavior effects. In fact, from
our perspective, this study goes a long
way in bringing the investigation of the
circadian system in mammals closer to
the sophisticated analysis that could pre-
viously only be carried out in the fly.
Importantly, it is neither the neuropep-
tide NMS itself nor its relative NMU that
are functionally essential, as double
knockouts of the neuropeptides remain
rhythmic (Lee et al., 2015). This raises
some intriguing questions: Does NMS
truly label a critical population of pace-
maker neurons? Of note, NMS-Bmal1
knockout mice continue to show rhyth-
micity for 12 days on average under con-
stant dark conditions. Could it be that the
main effect of the NMS genetic manipula-
tion is in fact due to the NMS driver also
mutating AVP neurons, which mostly
overlap with NMS expression? Or could
there be some type of mass action effect,
where regardless of the specific neuronal
sub-type being manipulated, altering
40% of SCN neurons, as done in both
studies discussed here, disrupts just
enough of this synchronized plexus of
neurons to impair the circadian circuit?
The VIP-Bmal1 knockout mouse showed
what looked like a normal circadian
rhythm, but the VIP cell population is
sparser than the AVP or NMS expressing
neurons. A prior study floxing out Bmal1
in up to 65% of the SCN using the pan-
neuronal Syt10 driver showed minimal ef-
fects on behavioral rhythms (Husse et al.,
2011). The larger Syt10-driven ablation,
along with older studies of partial SCN le-
sions and SCN transplantation rescue
studies, suggests that even a small per-
centage of intact SCN neurons is suffi-
cient to drive circadian behavior, and
argues against the possibility that mass
action underlies the effects observed us-
ing the NMS driver. It is also worth point-
ing out that previous work has demon-
strated that micro-lesions of a specific
region in the center of the hamster SCN
leads to behavioral and neuroendocrine85, March 4, 2015 ª2015 Elsevier Inc. 897
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Previewsarrhythmicity (Kriegsfeld et al., 2004). So it
is not as though all neurons in the SCN
have an equal, functional weight.
We believe these are early days in a
new era of understanding the microcir-
cuits that comprise the circadian pace-
maker in the SCN. Future work will need
to firmly link the molecular oscillator with
neuropeptide secretion and the neural
membrane events that form the backbone
of SCN pacemaking. The next generation
of ‘‘circuit breaking’’ tools such as opto-
genetics (Fan et al., 2015; Jones et al.,
2015) and DREADDs (Brancaccio et al.,
2013), along with more sophisticated
computational analysis (e.g., Evans et al.
[2013]), are starting to be applied to better
understand the SCN circuit that times our
daily lives.
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